Sotto receives Sinovac COVID-19 vaccine | Inquirer News

Sotto receives Sinovac COVID-19 vaccine

/ 03:43 PM May 22, 2021

Photo from the Office of the Senate President

MANILA, Philippines — Senate President Vicente Sotto III received the CoronaVac COVID-19 vaccine made by the Chinese pharmaceutical company Sinovac Biotech on Saturday at the Senate.

In a text message to reporters, Sotto said he got the Sinovac shot after Senate employees under the A1, A2, and A3 priority groups were given the jab.

Article continues after this advertisement

“After A1, A2, and A3 Senate Employees, finally had mine although I’m A2,” Sotto said.

FEATURED STORIES

“I took what was available upon arrival. Had Sinovac!” he added.

Photos sent by Sotto showed the Senate President receiving the injection on his left arm, as he was accompanied by his wife, actress Helen Gamboa.

/MUF
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: 2019-nCoV, COVID-19, COVID-19 Vaccine, GCQ, lockdown, nCoV update, Philippine news updates, Senate

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.